KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Goodwill & Intangibles (2016 - 2026)

Pacira BioSciences has reported Goodwill & Intangibles over the past 17 years, most recently at $373.0 million for Q1 2026.

  • For Q1 2026, Goodwill & Intangibles fell 18.28% year-over-year to $373.0 million; the TTM value through Mar 2026 reached $373.0 million, down 18.28%, while the annual FY2025 figure was $388.3 million, 8.84% down from the prior year.
  • Goodwill & Intangibles for Q1 2026 was $373.0 million at Pacira BioSciences, down from $388.3 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $755.3 million in Q1 2022 and troughed at $373.0 million in Q1 2026.
  • A 5-year average of $575.9 million and a median of $632.1 million in 2024 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: skyrocketed 289.25% in 2022 and later tumbled 34.11% in 2024.
  • Year by year, Goodwill & Intangibles stood at $703.8 million in 2022, then dropped by 8.14% to $646.5 million in 2023, then tumbled by 34.11% to $426.0 million in 2024, then fell by 8.84% to $388.3 million in 2025, then decreased by 3.93% to $373.0 million in 2026.
  • Business Quant data shows Goodwill & Intangibles for PCRX at $373.0 million in Q1 2026, $388.3 million in Q4 2025, and $402.7 million in Q3 2025.